We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
-4.31%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$171M
AUM Growth
-$7.17M
(-4%)
Cap. Flow
+$3.52M
Cap. Flow
% of AUM
2.05%
Top 10 Holdings %
Top 10 Hldgs %
65.95%
Holding
224
New
11
Increased
129
Reduced
70
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Syntax Stratified LargeCap ETF
SSPY
|
+$1.79M |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$263K |
| 3 |
Devon Energy
DVN
|
+$248K |
| 4 |
NXP Semiconductors
NXPI
|
+$243K |
| 5 |
PG&E
PCG
|
+$233K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$1.27M |
| 2 |
PVH
PVH
|
+$295K |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$242K |
| 4 |
ServiceNow
NOW
|
+$230K |
| 5 |
FRC
First Republic Bank
FRC
|
+$209K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.69% |
| 2 | Consumer Staples | 6.54% |
| 3 | Technology | 6.53% |
| 4 | Consumer Discretionary | 5.43% |
| 5 | Energy | 3.15% |
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q3 2022 Portfolio in Review
As of Q3 2022, Vantage Consulting Group held 224 positions worth $171M, down 4% from $178M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Vantage Consulting Group's Q3 2022 filing shows 11 new, 129 increased, 70 reduced and 11 closed positions. Its largest new stake was Coterra Energy: 9,167 shares worth $239K. The largest sale was Royalty Pharma, an estimated $1.27M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Consumer Staples and Technology.
- Vantage Consulting Group's largest Q3 2022 buy was Coterra Energy: 9,167 shares worth $239K.
- Vantage Consulting Group added most to Syntax Stratified LargeCap ETF in Q3 2022, an estimated $1.79M increase.
- Vantage Consulting Group's biggest Q3 2022 reduction was Royalty Pharma, cutting an estimated $1.27M.
- Vantage Consulting Group fully exited PVH in Q3 2022, selling an estimated $295K.
- Vantage Consulting Group's ten largest holdings make up 66% of its $171M portfolio in Q3 2022.
- Vantage Consulting Group opened 11 new positions and closed 11 in Q3 2022.
- Vantage Consulting Group's portfolio value fell 4% quarter-over-quarter to $171M.
Based on Vantage Consulting Group's 13F filing for Q3 2022, filed 14 Nov 2022.